Eduardo Rene Salas is of Intra-Cellular Therapies, Inc.. Currently has a direct ownership of 0 shares of ITCI, which is worth approximately $0. The most recent transaction as insider was on Apr 02, 2025, when has been sold 1,567 shares (Common Stock) at a price of $132.0 per share, resulting in proceeds of $206,844. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

Eduardo Rene Salas Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 02 2025
SELL
Sale (or disposition) back to the issuer
$206,844 $132.0 p/Share
1,567 Reduced 100.0%
0 Common Stock
Jun 23 2024
BUY
Exercise of conversion of derivative security
-
1,567 Added 50.0%
1,567 Common Stock

Also insider at

ADMA
ADMA BIOLOGICS, INC. Healthcare
ERS

Eduardo Rene Salas

New York, NY

Track Institutional and Insider Activities on ITCI

Follow Intra-Cellular Therapies, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITCI shares.

Notify only if

Insider Trading

Get notified when an Intra Cellular Therapies, Inc. insider buys or sells ITCI shares.

Notify only if

News

Receive news related to Intra-Cellular Therapies, Inc.

Track Activities on ITCI